from Reuters: Health News https://ift.tt/2r7mXFz
Tuesday, November 27, 2018
Tuesday, November 27, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Britain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.

from Reuters: Health News https://ift.tt/2r7mXFz
from Reuters: Health News https://ift.tt/2r7mXFz
Related Posts:
LATEST HEALTH NEWSComplacency is starting to stall the fight against the global AIDS epidemic, with the pace of progress not matching what is needed, the United Nations warned on Wednesday. from Reuters: Health News https://ift.tt/2msv8Kg… Read More
LATEST HEALTH NEWSAbout 68% of the Indian population has limited or no access to essential medicines from Health https://ift.tt/2O2C5xZ … Read More
LATEST HEALTH NEWSA low-budget Chinese movie about a leukemia patient who turns to smuggling cheaper cancer drugs from India has struck a chord with Internet users and even the country's leaders, spotlighting national anxieties about unaf… Read More
LATEST HEALTH NEWSHundreds of farmers from around Bulgaria rallied in the capital Sofia on Wednesday against the government-ordered mass slaughter of livestock following the first outbreak in the European Union of the highly contagious Peste d… Read More
LATEST HEALTH NEWSAstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in preparation for potential disruption if the UK crashes out of the EU without a deal. … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment